Haemonetics Corporation (NYSE:HAE) is seeking acquisitions. Chris Simon, Chairman and Chief Executive Officer of Haemonetics Corp, said, "There are a number of things that we are looking for that team to do to drive the growth of homeostasis, cell salvage and transfusion management. We are building capabilities. We are strengthening our operational core, it has not been historically part of the Company's DNA and we are investing against that and we are going to exceed both exhilarated organic growth and importantly this is a place where the Company in baby steps, modest steps, will look to do inorganic, tuck-in type acquisitions, things that are immediately accretive not just in a financial sense but actually operational sense and create real operating leverage in our hospital business unit P&L."